The FDA has issued a recall of over 140,000 bottles of cholesterol medication due to "failed dissolution specifications." ...
The Food and Drug Administration recalled hundreds of thousands of bottles of the cholesterol drug Atorvastatin Calcium ...
The FDA said that over 140,000 bottles of the Lipitor generic potentially failed to meet "dissolution specifications." ...
Nearly 142,000 bottles of atorvastatin calcium tablets recalled nationwide • Faulty dissolution may limit drug absorption and ...
Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.
In a major trademark dispute between two prominent names in the pharmaceutical and nutraceutical industry, the Delhi High ...
FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs ...
The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets ...
The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...
Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC), functioning under the Central Drug Standard ...
Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback